FluGen, Inc.

At FluGen we’re dedicated to preventing serious illness in humans by developing the most effective vaccine in the world against all forms of the deadly influenza virus. Based in Madison, Wisconsin and founded, staffed and supported by some of the world’s top scientists, FluGen has developed REDEE FLU™, an influenza vaccine that is scheduled to enter human trials in 2014. FluGen offers investors an exciting opportunity to get involved with a cutting edge biotech company and, more importantly one that offers the world the promise of a more effective, life saving vaccine. We are fighting a virus that mutates quickly and results in over 200,000 hospitalizations and up to 36,000 deaths each year in theU.S.alone. Worldwide,these statistics are even more staggering. Now is the time to invest our time and resources into a new and more effective fight against influenza.